- Home
- VOR vs TVGN Comparison
VOR vs TVGN Comparison
Compare VOR & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$11.63
Company Overview
Basic Information| Metric | VOR | TVGN |
|---|---|---|
| Founded | 2015 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 207.1M | 89.6M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | VOR | TVGN |
|---|---|---|
| Price | $11.63 | $0.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | ★ $66.63 | $5.00 |
| AVG Volume (30 Days) | ★ 3.6M | 1.5M |
| Earning Date | 11-13-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.62 | $0.30 |
| 52 Week High | $65.80 | $1.92 |
Technical Indicators
Market Signals| Indicator | VOR | TVGN |
|---|---|---|
| Relative Strength Index (RSI) | 44.77 | 41.35 |
| Support Level | $12.26 | $0.30 |
| Resistance Level | $15.00 | $0.41 |
| Average True Range (ATR) | 1.76 | 0.03 |
| MACD | 0.18 | 0.00 |
| Stochastic Oscillator | 0.00 | 49.69 |
Price Performance
Historical Comparison VOR
TVGN
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
About TVGN Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.